表观扩散系数(ADC)在MRI上鉴别视网膜母细胞瘤与Coats病
回顾性横断面研究纳入2018年1月1日至2022年1月8日期间诊断为Coats病或视网膜母细胞瘤且MRI可评估的18岁以下儿童,比较眼内病变的表观扩散系数(ADC)。视网膜母细胞瘤患者平均ADC为442±210 mm²/s,Coats病患者为1364±309 mm²/s,差异有统计学意义(P < .001);在本数据集中900 mm²/s阈值有助于高准确度区分两种诊断。
要点
- 视网膜母细胞瘤平均ADC为442±210 mm²/s,Coats病为1364±309 mm²/s,差异有统计学意义(P < .001)。
- 在本数据集中,900 mm²/s阈值有助于高准确度区分视网膜母细胞瘤与Coats病。
- ADC值在不同扫描仪和DWI脉冲序列间可能不同,阈值可能难以在各机构间通用。
核心结论
- 视网膜母细胞瘤与Coats病的临床特征常相似,可导致误诊;ADC作为源自扩散加权MRI的客观参数,在怀疑视网膜母细胞瘤和/或Coats病时有可能辅助建立或确认诊断。
研究设计与样本
- 回顾性横断面研究,纳入2018年1月1日至2022年1月8日期间诊断为Coats病或视网膜母细胞瘤且MRI可评估的18岁以下儿童。
- 回顾性获取5例Coats病患者的5只眼和23例视网膜母细胞瘤患者的29只眼的脑MRI资料,所有MRI均在治疗前获得。
- 使用Epic默认查看器(Ambra DICOM)中的滴管工具测量MRI所见眼内病变内5至8个随机采样点的ADC,计算每只患眼的平均ADC。
- 通过随机抽样患者并设盲于诊断和先前测量值重新测量平均ADC以确认内部可靠性,采用t检验判断两组ADC值是否存在差异。
主要发现
- 视网膜母细胞瘤患者平均ADC为442±210 mm²/s,Coats病患者平均ADC为1364±309 mm²/s,差异有统计学意义(P < .001)。
- 基线测量与重复测量之间的t检验无显著差异。
- 在本数据集中,900 mm²/s阈值有助于高准确度区分两种诊断。
关键数值与推荐
- 视网膜母细胞瘤患者平均ADC为442±210 mm²/s,Coats病患者平均ADC为1364±309 mm²/s(P < .001)。
- 在本数据集中,900 mm²/s阈值有助于高准确度区分视网膜母细胞瘤与Coats病。
临床怎么用
- 原文未据此给出推荐。
局限性
- ADC值可在不同扫描仪和DWI脉冲序列间存在差异,阈值可能难以在各机构间通用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Coats' disease can be difficult to differentiate from retinoblastoma. While MR imaging of retinoblastoma and Coats' disease have been examined for differentiating features such as eye size, vitreous seeding, and shape of retinal detachment, there is a lack of data on apparent diffusion coefficient (ADC). ADC is a measure of the diffusion (of water molecules) within tissue, and is commonly clinically calculated using MRI. DESIGN: Retrospective cross-sectional study. METHODS: Patient or study population: Children < 18 diagnosed with Coats disease or Retinoblastoma between January 1, 2018 and January 8, 2022 who had MRI imaging that was reviewable. MAIN OUTCOME MEASURE: Apparent diffusion coefficient (ADC) of the intraocular lesion. Retrospective brain MRIs were obtained from records of 5 eyes of 5 Coats' patients and 29 eyes of 23 patients with retinoblastoma. All MRIs were obtained prior to treatment. The eyedropper tool in Epic's default viewer (Ambra DICOM) was used to measure the ADC of five to eight randomly sampled points within the eye lesions seen on MRI. Average ADC was calculated for each affected eye. Internal reliability was confirmed by re-measuring mean ADC for a random sample of patients masked to their diagnosis and prior measurements. T-test was used to determine if ADC values differ between groups. RESULTS: The mean ADC for retinoblastoma patients (442 +/- 210 mm2/s) differed significantly from the mean for Coats' patients (1364 +/- 309 mm2/s), (P < .001). T-test between baseline and repeat measurements was not significantly different. Since ADC values can differ between different scanners and DW MRI pulse sequences, an ADC threshold may be difficult to generalize across institutes, in our data set a threshold of 900 mm2/s was useful in separating the two diagnoses with a high degree of accuracy. CONCLUSIONS: Clinical features of retinoblastoma and Coats' disease often resemble each other and can lead to misdiagnosis. Since ADCs are derived from diffusion-weighted MRI as an objective parameter, it has the potential to aid in establishing or confirming the diagnosis when retinoblastoma and/or Coats' disease are suspected.
引用
- Zhang WX, Shimony JS, Lueder GT, et al. Apparent Diffusion Coefficient (ADC) Differentiates Retinoblastoma from Coats Disease on MRI. Am J Ophthalmol. 2024. PMID: 38866359. doi:10.1016/j.ajo.2024.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。